Vaccines against Toxoplasma gondii: challenges and opportunities.


Development of vaccines against Toxoplasma gondii infection in humans is of high priority, given the high burden of disease in some areas of the world like South America, and the lack of effective drugs with few adverse effects. Rodent models have been used in research on vaccines against T. gondii over the past decades. However, regardless of the vaccine… (More)


Cite this paper

@article{Jongert2009VaccinesAT, title={Vaccines against Toxoplasma gondii: challenges and opportunities.}, author={Erik Jongert and Craig W Roberts and Nicola Gargano and Elisabeth F{\"{o}rster-Waldl and Eskild Petersen}, journal={Memorias do Instituto Oswaldo Cruz}, year={2009}, volume={104 2}, pages={252-66} }